MedPath

Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers

Completed
Conditions
Bleeding Peptic Ulcer
Registration Number
NCT02245802
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

This study aimed to validate CU prediction model on mortality for patients with high risk bleeding peptic ulcers after therapeutic endoscopy.

Detailed Description

Despite advances in management of patients with bleeding peptic ulcers, mortality is still 10%. We previously reported a prediction score for ulcer bleeding related mortality developed from a local cohort. The risk factors for mortality included patients older than 70, presence of co-morbidity, more than one listed co-morbidity, hematemesis, SBP \< 100 mmHg, in-hospital bleeding, rebleeding, and need for surgery.

Study objective This study aimed to validate the prediction of mortality among patients with bleeding peptic ulcers from different Asian countries.

Method Consecutive patients with bleeding peptic ulcers who presented to the study centers in Hong Kong, Japan and Taiwan were recruited after successful primary endoscopic hemostasis. The baseline demographics, ulcer characteristics, the predictive factors, 30 days mortality, rebleeding, hospital stay and need of surgery were recorded. The accuracy of prediction for adverse events including mortality and rebleeding with the prediction risk scoring system would be analysed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
785
Inclusion Criteria
  1. Patients presented with bleeding peptic ulcers
  2. Age > 18 year old
  3. Informed consent for the study and OGD
Read More
Exclusion Criteria
  1. Unable or refuse to give consent
  2. Onset more than 7 days
  3. Pregnancy
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Accuracy in prediction of peptic ulcer bleeding related mortality30 days

The CU prediction score would be calculated from addition of all the risk factors scores. . The calculated predictive score collected from the whole group of patients would be analyzed using the receiver operating characteristic (ROC) curve and represented using the area under curve (AUC). An AUC of 0.5 would be interpreted as poor predictive power whereas a value of 1.0 would indicate excellent predictive power.

Secondary Outcome Measures
NameTimeMethod
Complication rate30 days
Hospital stay30 days
Mortality difference between high risk and low risk group30 days
Need of Transfusion30 days

Need of transfusion as represented by number of units transfused

Need of Surgery30 days

Trial Locations

Locations (1)

Combined Endoscopy Center, Prince of Wales Hospital

🇨🇳

Hong Kong SAR, China

© Copyright 2025. All Rights Reserved by MedPath